Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zyvex Technologies, originally founded as Zyvex Performance Materials, is a molecular nanotechnology company specializing in the development and commercialization of carbon nanotube-enhanced materials. The company utilizes its proprietary Kentera functionalization platform to effectively disperse and chemically bond carbon nanotubes into various polymer matrices, significantly improving the mechanical and electrical properties of the resulting composites. Its flagship products, including Arovex carbon fiber prepregs and Epovex resins, are widely utilized in high-performance applications across the aerospace, marine, and automotive sectors. While primarily an industrial materials firm, Zyvex also provides specialized solutions for the healthcare industry, such as lightweight, high-strength components for medical imaging systems and advanced prosthetic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zyvex Performance Materials.